TOGARAM2 and idiopathic pulmonary fibrosis: We found that 67 out of 68 (excluding TOGARAM2) are differentially expressed in the blood cells of IPF patients, which holds the potential for aiding in the development of non-invasive diagnostic approaches for this patient population.